Literature DB >> 25545159

A convenient method for the synthesis of (prop-2-ynyloxy)benzene derivatives via reaction with propargyl bromide, their optimization, scope and biological evaluation.

Tannaza Batool1, Nasir Rasool1, Yasmeen Gull1, Mnaza Noreen1, Faiz-ul-Hassan Nasim2, Asma Yaqoob2, Muhammad Zubair1, Usman Ali Rana3, Salah Ud-Din Khan3, M Zia-Ul-Haq4, Hawa Z E Jaafar5.   

Abstract

A highly convenient method has been developed for the synthesis of (prop-2-ynyloxy) benzene and its derivatives. Differently substituted phenol and aniline derivatives were allowed to react with propargyl bromide in the presence of K2CO3 base and acetone as solvent. The compounds were synthesized in good yields (53-85%). Low cost, high yields and easy availability of compounds helped in the synthesis. Electron withdrawing groups favor the formation of stable phenoxide ion thus in turn favors the formation of product while electron donating groups do not favor the reaction. Phenol derivatives gave good yields as compared to that of aniline. As aprotic polar solvents favor SN2 type reactions so acetone provided best solvation for the reactions. K2CO3 was proved to be good for the synthesis. Antibacterial, Antiurease and NO scavenging activity of synthesized compounds were also examined. 4-bromo-2-chloro-1-(prop-2-ynyloxy)benzene 2a was found most active compound against urease enzyme with a percentage inhibition of 82.00±0.09 at 100 µg/mL with IC50 value of 60.2. 2-bromo-4-methyl-1-(prop-2-ynyloxy)benzene 2d was found potent antibacterial against Bacillus subtillus showing excellent inhibitory action with percentage inhibition of 55.67±0.26 at 100 µg/ml wih IC50 value of 79.9. Based on results, it can be concluded that some of the synthesized compounds may have potential antiurease and antibacterial effects against several harmful substances.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25545159      PMCID: PMC4278708          DOI: 10.1371/journal.pone.0115457

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


Introduction

(Prop-2-ynyloxy)benzene is an important compound having vast synthetic applications. Most important of all of its applications is its use as triazole intermediate [1]. Synthetic methods of organic chemistry reveal alkyne groups to be most reactive ones which increase the importance of the compound [2]. Low cost, high yield of the compound has attracted the attention of scientists to synthesize the compound as monomer for many polymeric compounds as it is thermally reactive end capping agent. [3] The reaction became much more important due to presence of terminal alkyne which helps in easy polymerization reactions under mild reaction condition, low temperature which is more favorable for linear and graft polymeric compounds. [4] (Prop-2-ynyloxy)benzene structure is mainly found in compounds of medicinal importance specially of antimicrobial importance. [5] (Prop-2-ynyloxy)benzene type compounds are also used in synthesis of large number of polymeric compounds mainly included lignin [6], azide functionalized dendrons [7], and β lactam fused enediynes [8], mono and bis-1,2,3-triazole acyclonucleoside [9], symmetrical and asymmetrical, cyclic and acylic enediynes [10] and sulfonated polytriazole proton exchange membrane for methanol feul cells via click chemistry. [4] Synthetic importance of the compound is revealed from its structure having easy approach for upcoming substances joining them to form complex molecules more accurately with great ease [11]. Haung and coworkers observed that (Prop-2-ynyloxy)benzene type compounds showed antimicrobial, antitumor, anti HIV, DNA scavenging inhibitors, anti proliferating, anti obesity and central nervous system activities. [4] The main intention of the present work is the synthesis of (Prop-2-ynyloxy)benzene derivatives by reported methodologies [12]–[20] and our focused to adopt optimization reaction condition such as effect of solvents, moler concentration of bases, stirring and refluxing time. In addition evaluating their antibacterial, antiurease and NO scavenging activities.

Results and Discussion

Chemistry

Krim and co-workers reported that (Prop-2-ynyloxy)benzene is an intermediate in the synthesis of triazole via Huigen dipolar cycloaddition method using click chemistry. Terminal alkynes provide an efficient method for the synthesis of triazole, [21] which can be prepared by reaction of 3-Bromopropyne and aniline derivatives in DMF [9], [22]. We reported the reaction of phenol and propargyl bromide for the synthesis of (Prop-2-ynyloxy)benzene derivatives under different reaction conditions. [23]–[28] There is very little work on the synthesis of reported compounds under these optimized reaction conditions and so far no information was published for antibacterial, antiurease and NO scavenging activity of the synthesized compounds. We optimized the reaction conditions like temperature, solvents, bases and its concentration for the synthesis of compounds (2a–2f) (Fig. 1, Table 1). It was observed that successive addition of various bases and solvent types helped to obtain moderate to very good yields (74–85%) of synthesized compounds. For the synthesis of compound (2d) 2-bromo-4-methyl-1-(prop-2-ynyloxy) benzene, 2-bromo-4-methyl phenol (0.535 mmol) was reacted with propargyl bromide (1.2 eq.) in THF using LiH (2 eq.) as base at room temperature producing no product. It was noted that 2d was synthesized with almost 74% yield, when the reaction was carried out in acetone and K2CO3 (2 eq.) under reflux conditions for 5 hrs. Compound, 1-nitro-4-(prop-2-ynyloxy) benzene (2f) was prepared by using dry acetone and K2CO3 (3.5 eq.) under reflux conditions for 5 hour producing 76% yield. However when compound was first stirred in the presence of K2CO3 (3.5 eq.) and acetone at room temperature for 2 hour then adding propargyl bromide (1.3 eq.) to the reaction mixture and stirring for 16 hour resulted in 53% yield. It was surprisingly noted that acidity of phenoxide ion was also affected by nature of substitutions. Electron withdrawing groups might increase the acidity to led enhanced yield of products while electron donating groups allowed to decrease the yield of synthesized compounds (Fig. 1, Table 1).
Figure 1

Synthesis of compounds 2a–f.

Table 1

Optimization of reaction conditions for compounds 2a–2f.

EntryReactantProductSolventsBaseTemp.Time* Yield*
1C6H4OBrClC9H6OClBr 2a AcetoneK2CO3 80°C5 h79%
2C6H4OBrClC9H6OClBr 2b AcetoneK2CO3 80°C5 h78%
3C6H4OBr2 C9H6OBr2 2c AcetoneK2CO3 80°C5 h85%
4C9H7OBrC10H9OBr 2d THFLiHr.t24 h0%
AcetoneK2CO3 80°C5 h74%
5C6H4OBrFC9H6OBrF 2e AcetoneK2CO3 80°C5 h79%
6C9H5O3NC9H7O3N 2f AcetoneK2CO3 80°C30 h53%
AcetoneK2CO3 80°C5 h76%

*Time checked by TLC.

*Isolated Yield.

*Time checked by TLC. *Isolated Yield. Compound 4a and 4b were prepared by reaction of 4,4′-(propane-2,2-diyl)diphenol (0.87 mmol) and 4,4′-sulfonyldiphenol (0.8 mmol) with propargyl bromide (2.4 eq.) in acetone using K2CO3 (4 eq.) as base under reflux conditions (80°C) respectively. (Fig. 2, Table 2). It was noteworthy that 4b gave very good yield (73%) due to more acidic protons of 4,4′-sulfonylbis((prop-2-ynyloxy)benzene) while 4a gave moderate yield (70%) of 4,4′-(propane-2,2-diyl)bis((prop-2-ynyloxy)benzene) due to less acidic protons because of two methyl moieties present in the molecule.
Figure 2

Synthesis of compounds 4a–b.

Table 2

Optimization of reaction conditions for compounds 4a–b.

EntryReactantProductBaseSolventTimeTemp.Yield
1 C15H16O2 C21H20O 4a K2CO3 Acetone5 h80°C70%
2 C12H10O4S2 C14H14S2O2 4b K2CO3 Acetone5 h80°C73%
It was observed that naphthalene-1-ol (0.694 mmol) were allowed to react with propargyl bromide (1.2 eq.) in the presence of K2CO3 base (3.5 eq.) and 3 ml dry acetone as solvent to synthesize 1-(prop-2-ynyloxy)naphthalene 6a, (71%). Naphthalene-2-ol (0.694 mmol) was first stirred in the presence of K2CO3 (3.5 eq.) and acetone at room temperature for 2 hour then adding propargyl bromide (1.3 eq.) to the reaction mixture and stirring for 16 hour resulted in 73% yield of 2-(prop-2-ynyloxy)naphthalene 6b. The reaction completion was monitored by TLC. No product was formed while refluxing the reaction mixture with 1 eq. of K2CO3 base. It was surprisingly noted that increasing the eq. of K2CO3 base led to reaction completion (Fig. 3, Table 3).
Figure 3

Synthesis of compounds 6a–b.

Table 3

Optimization of reaction conditions for compounds 6a–b.

EntryReactantProductBaseReactionSolventTimeYield
1 C10H8OC13H10O 6a K2CO3 CompleteAcetone15 h71%
2 C10H8OC13H10O 6b K2CO3 CompleteAcetone30 h73%
Moreover substituted aniline 7 (2.68 mmol) and 7a (0.699 mmol) were reacted with propargyl bromide (1.3 eq.) to synthesize variously substiuted (prop-2-ynyl)anilines, 8a–8d (Fig. 4, Table 4). It was noteworthy that reaction time was prolonged as compared to phenolic compounds to provide more harsh conditions in order to obtain desired products. In the presence of 1 eq. K2CO3 base 7a was allowed to react with propargyl bromide (1.3 eq.), it was surprisingly noted that reaction was failed however using 2–3 eq. base proved helpful for the completion of reaction with very good yield of 8d (69%).
Figure 4

Synthesis of compounds 8a–d.

Table 4

Optimization of reaction conditions for compounds 8a–d.

EntryReactantProductBaseTemp.SolventTimeYield
1 C7H8NBrC10H10NBr 8a K2CO3 80°CAcetone20 h68%
2 C7H8NBrC10H10NBr 8b K2CO3 80°CAcetone20 h71%
3 C7H8NBrC10H10NBr 8c K2CO3 80°CAcetone20 h70%
4 C10H9NC13H11N 8d K2CO3 80°CAcetone15 h69%
We explained a similar application of present method to obtain 10, N-(prop-2-ynyl)-4-(prop-2-ynyloxy)aniline (Fig. 5, Table 5). It was observed that reaction was carried out at room temperature by 16 hour stirring of 4-aminophenol (0.917 mmol) and K2CO3 (2 eq.) as base with addition of propargyl bromide (2.4 eq.) in DMF as solvent during time interval of 20 min, after this reaction mixture was refluxed for 48 h under nitrogen atmosphere to obtain desired product 10, no product was formed. It was noteworthy that when the reaction was done with K2CO3 (4 eq.) as base in dry acetone as solvent, compound 10 was obtained with 76% yield.
Figure 5

Synthesis of compound 10.

Table 5

Optimization of reaction conditions for compound 10.

EntryReactantProductSolventsBaseTempTimeYield
1 C6H7ONC15H13ONDMFK2CO3 80°C64 h0%
AcetoneK2CO3 80°C10 h76%
Reaction of 11 4-amino-5-hydroxynaphthalene-2,7-disulfonic acid (0.313 mmol) and 11a 4-amino-3-hydroxynaphthalene-1-sulfonic acid (0.418 mmol) with propargyl bromide (2.7 eq.) in basic conditions did not confirm the formation of any product. It was noted that the reaction failed even after addition of excess quantities of base and refluxing the reaction for prolonged time (Fig. 6). It might be possible that failure of reactions were due to presence of sulfonic acid functionality present in the molecule.
Figure 6

Synthesis of compounds 12a–b

.

Synthesis of compounds 12a–b

.

Pharmacology

Antiurease activity

Electron donating groups enhance the activity of compounds by donating the electrons to phenyl group which enhances the binding of enzyme active site and the molecule easily [29]. Bromine containing compounds more easily inhibit the urease activity rather than compounds containing fluorine and chlorine due to lesser electronegativity values of bromine. Methyl substituent and sulfur moiety also increases the activity of compounds [30]. The compounds were tested to inhibit the activity of urease enzyme at 50 µg/ml and 100 µg/ml concentrations and their results are given in table 3. Thiourea was used as positive control with percentage inhibition activity of 65±0.01 with IC50 value of 23.3 at 40 µg/ml. The results revealed that electronic effects of aryl substitutions are playing a significant role in activity manipulation. 2a, 2b and 2e contain bromine substitution which enhances their activity due to lesser withdrawing effect. Chloro and flouro groups decrease the activity of compounds due to more withdrawing effect. 4a also exhibited remarkable results due to presence of methyl moieties. 2f surprisingly gave contrasting results. As nitro group has withdrawing electronic effect, which decreases the inhibitory effect of synthesized compound. But results showed comparatively good results for the respective compound. It was observed that all synthesized compounds 2a-10 showed moderate to very good urease inhibition activity. 4-bromo-2-chloro-1-(prop-2-ynyloxy)benzene 2a showed comparatively good results with a percentage inhibition of 42.5±0.7 at 50 and 82.00±0.09 at 100 µg/mL with IC50 value of 60.2. The 2b–6a showed good inhibition activities with percentage inhibition of 81.07±0.1, 86.45±0.07, 85.89±0.07, 79.59±0.11, 65.8±0.18, 89.42±0.05, 74.9±0.13, 65.3±0.18 at 100 µg/ml with IC50 values ranging between 64.92, 70.1, 67.14, 62.15, 63.7, 62.3, 70.9 and 68 µg/ml respectively (Table 6). 6b did not show any satisfactory results.
Table 6

Urease inhibition studies of (prop-2-ynyloxy)benzene.

CompoundPercentage inhibition at 50 ug/mLPercentage inhibition at 100 ug/mLIC50 (ug/mL)
2a 42.5±0.782.00±0.0960.2
2b 31.5±0.2281.07±0.1064.92
2c 36±0.586.45±0.0770.1
2d 30.33±0.685.89±0.0767.14
2e 40±0.579.59±0.1162.15
2f 44±0.4365.8±0.1863.7
4a 37±0.3489.42±0.0562.3
4b 32±0.2874.9±0.1370.9
6a 41.33±0.4165.3±0.1868
6b 32±0.3841.9±0.313---
8a 25±0.4555.65±0.23990.7
8b 27±0.4550.83±0.26598.2
8c 32±0.3845.26±0.295---
8d 43±0.4251.5±0.2691.7
10 25±0.4556.5±0.23489.6
20 ug/ml40 ug/ml
Thiourea47.1±0.3165±0.0123.3
Aniline derivatives showed comparatively lesser activities due to lack of binding site at tertiary amine site. Ni acts as cofactor for urease enzyme, which helps in chelation of ions by compounds containing amino groups, thus activating the enzyme activity but in tertiary amines, chelation do not occur easily. Compound 8a-10 (Table 6) showed low inhibition activities with inhibition values of 55.65±0.239, 50.83±0.265, 56.5±0.234, 51.5±0.26 at 100 µg/ml with IC50 values of 90.7, 98.2, 89.6 and 91.7 µg/ml respectively. Compound 8c did not show any satisfactory results.

Nitric oxide (NO) scavenging activity

Nitric oxide is a free radical causing oxidative damage to biomolecules, finally leading to many disorders like cancer [31], aging and diabetes [32]. The synthesized compounds (2a-10) exhibited good nitric oxide scavenging activity. Vitamin C (Ascorbic acid) was used as a control with percentage inhibition values 38.5±0.16 at 50 and 84.1±0.12 at 100 µg/mL with IC50 value 50.43. Electron withdrawing groups decreases the activity while electron donating groups enhances the nitric oxide scavenging activity. Bromine containing compounds exhibited more activity as 2c has maximum inhibitory activity due to the presence of two bromine groups attached to aromatic ring. 4a also exhibited remarkable results due to the presence of methyl moieties having donating effects thus enhancing the activity. 2a, 2b and 2e have relatively lower IC50 values due to electron withdrawing effects of fluorine and chlorine groups. 4b having SO2 groups showed lesser inhibitory activity. Aniline derivatives also showed lower inhibitory activity as compared to that of phenolic ones. Compounds 2,4-dibromo-1-(prop-2-ynyloxy)benzene 2c and 4,4′-(propane-2,2-diyl)bis((prop-2-ynyloxy)benzene) 4a were found good percentage inhibitors against NO free radicals with value 39.67±0.09 at 50 µg/mL and 77.03±0.11 at 100 µg/mL with IC50 value 63.8 and percentage inhibition 40±0.09 at 50 µg/mL and 74.53±0.13 at 100 µg/mL with IC50 value 64.4 respectively. 2a, 2b and 2e exhibited fairly good NO percentage inhibition (76.09±0.12, 68.44±0.16 and 77.5±0.11 at 100 µg/mL) with IC50 values 67.72, 67.9 and 68.8 respectively (Table 7). Compounds 2d, 4b-10 were comparatively less active to scavenge NO free radicals (69.95±0.15, 59±0.15, 63.17±0.19, 65.19±0.18, 68.65±0.16, 57.98±0.21, 62.8±0.19 and 65.5±0.18 at 100 µg/mL) with IC50 values 89.6, 83, 76.16, 79.4, 87.5, 78 and 78.1 for each compound respectively. 1-nitro-4-(prop-2-ynyloxy)benzene 2f and N-(prop-2-ynyl)naphthalen-1-amine 8d did not show any significant results and aniline derivatives showed lesser activity than that of phenol.
Table 7

Nitric oxide scavenging activity.

CompoundPercentage scavenging activity at 50 ug/mlPercentage scavenging activity at 100 ug/mlIC50 ug/ml
2a 35.67±0.0976.09±0.1267.72
2b 39.67±0.0968.44±0.1667.9
2c 39.67±0.0977.03±0.1163.8
2d 31.33±0.1069.95±0.1574.1
2e 33.33±0.177.5±0.1168.8
2f 32±0.1047.01±0.27---
4a 40±0.0974.53±0.1364.4
4b 15.33±0.1259±0.1589.6
6a 24.33±0.1263.17±0.1983
6b 33.33±0.165.19±0.1876.16
8a 23.33±0.1168.65±0.1679.4
8b 26.33±0.1157.98±0.2187.5
8c 33.66±0.0962.8±0.1978
8d 7.67±0.1338.38±0.32---
10 30±0.1065.5±0.1878.1
Vit.C control 38.5±0.1684.1±0.1250.43

Antibacterial activity

Disc diffusion method was adopted to test the antibacterial activity of synthesized compounds 2a-10 against four different bacterial strains. Ampiciline was used as positive control to check antibacterial activity of synthesized compounds. The bacterial strains employed were: Escherichia coli, Bacillus subtillus, Shigella flexneri, Staphylococcus aureus, Pseudomonas aeroginosa and Salmonella typhi. Antibacterial activity of synthesized compounds 2a–2e, 4a, 4b and 10 showed moderate activity against Staphylococcus aureus while 2f, 6a and 8a–8d were found to be inactive (Table 8).
Table 8

Antibacterial activity of (prop-2-ynyloxy)benzene derivatives.

Compound Staphylococcus aureus Bacillus subtillus
40 ug/ml100 ug/mlIC50 ug/ml50 ug/ml100 ug/mlIC50 ug/ml
2a 29.13±0.1251±0.597.742.4±0.3534.9±0. 5NA
2b 31.47±0.1956±0.0787.740.37±0.3539.3±0.36NA
2c 31.47±0.256±0.187.739.4±0. 7555.01±0.2583.79
2d 27.67±0.3552±0.60795.941.5±0.35.67±0.2679.9
2e 31.99±0.0758±0.985.19.2±0. 957.9±0. 75NA
2f 18.66±0.339±0.4NA6.2±0. 6557.9±0.2587.5
4a 29.06±0.650±0.297.73.6±0. 2533.9±0.45NA
4b 26.86±0.3553±0.794.211.7±0. 1550.9±0.3497.6
6a –1.85±0.310±0.9NA5.5±0. 9252.5±0. 792.6
6b 21.44±0.451±0.398.339.06±0.0557.8±0.2679.2
8a 16.91±0.733±0.8NA30.5±0.3653.6±0.2292.2
8b 13.39±0.536±0.8NA39.4±0. 843.8±0.35NA
8c 15.95±0.6935±0.2NA38.8±0. 1536.0±0.39NA
8d 5.85±0.831±0.2NA17.5±0. 1545.8±0. 9NA
10 24.4±0.1152±0.196.36.13±0.350.7±0. 9598.5
Ampicilline 29.9±0.5973±0.51769.9±0.519. 8±0.2381
Hence compounds 2c, 2f, 4b–8a and 10 have batter activity against Bacillus subtillus. It was noted that 2d was found potent antibacterial against Bacillus subtillus showing good inhibitory action. 2a, 2b, 2e, 4a, and 8b–8d did not show any satisfactory result aginst Bacillus subtillus and were found to be inactive (Table 8). All of the synthesized compounds 2a-10 were proved inactive against Escherichia coli, Shigella flexneri, Pseudomonas aeroginosa and Salmonella typhi providing no significant results.

Materials and Methods

Ethics statement

No specific permits were required for these field studies. No specific permissions were required for these locations/activities because they were not carried out on privately owned or protected areas. The field studies did not involve endangered or protected species.

General

Melting points were determined using a Buchi melting point B-540 apparatus. All reagents used were purchased from Alfa Aesar, Sigma Aldrich and E. Merck Company. 13C-NMR and 1 H-NMR spectra were recorded on Bruker ARX 400 MHz FT-NMR spectrophotometer and Bruker ARX 600 MHz FT-NMR spectrophotometer while relishing CDCl3 as internal reference for the recording of spectra. The chemical shift was given in δ in ppm and coupling constant in Hz. EI-MS spectras were recorded on a JMS-HX-110 spectrometer, with a data system. For column chromatography technique, silica gel (70–230 mesh) and silica gel (230–400 mesh) were used. The reactions were monitored on TLC, using Merk Silica gel 60PF254 cards. The compounds were visualized by UV lamp (254, 365).

General procedure for the synthesis of (Prop-2-ynyloxy)benzene derivatives

The synthesis of (Prop-2-ynyloxy)benzene derivatives was carried out by using four methods.

Method A

To 1 eq (0.1 g) phenol (Figs. 1–6) added (1.2–2.7 eq.) propargyl bromide and (2–4 eq.) K2CO3 in acetone (3 ml). The reaction mixture was refluxed at 80°C till reaction completion based on TLC monitoring. On completion the reaction mixture was cooled up to room temperature and solvent was removed under reduced pressure. The residue was dissolved in distilled water and then extraction was done by twice addition of methylene chloride. Organic layer was separated and dried with the help of anhydrous magnesium sulphate. Solvent was removed under reduced pressure to obtain the desired product. After evaporation and filtration process the product was purified by flash chromatography. 60/40 mixture of hexane and ethyl acetate was used as eluent [5], [33]–[34].

Method B

1 eq (0.1 g) of phenol (Fig. 1) and (1.2 eq.) of LiH was stirred in 6 ml of THF at room temperature for 30 min, added (2 eq.) propargyl bromide to the reaction mixture and stirred overnight at room temperature. Reaction completion was monitored by TLC conditions. Evaporated the solvent under reduced pressure to obtain the final product. Product was purified by flash chromatography. 60/40 mixture of hexane and ethyl acetate was used as eluent [9], [35].

Method C

Phenol (Fig. 1 and 3) 1eq (0.1 g) and K2CO3 (3.5 eq.) was stirred at room temperature for two hours in 0.6 ml acetone. Propargyl bromide (1.3 eq.) in 1.66 ml acetone was added in 20 min and refluxed the reaction mixture for 16 hours under nitrogen atmosphere. Reaction completion was monitored by TLC. After the reaction completion solvent was removed under reduced pressure. The residue was dissolved in distilled water and organic layer was extracted using dichloromethane thrice. Additional water was removed by drying with anhydrous MgSO4 [11], [36].

Method D

1 eq (0.1 g) of 4-aminophenol (Fig. 5) and (3.5 eq.) anhydrous potassium carbonate in 0.6 ml dry DMF was stirred at room temperature for about 16 hours. 2.4 eq propargyl bromide in 0.48 ml dry DMF was added slowly in about 15 min. the reaction mixture was heated at 80°C for 48 hours under nitrogen atmosphere. Reflux conditions were used for heating the reaction mixture. Reaction completion was monitored by TLC and reaction time varied according to the condition of product. After reaction completion the solvent was removed reduced pressure. Residue was dissolved in water and then organic compound was extracted by addition of dichloromethane thrice the volume of water. Excess water was removed by adding MgSO4. The solvent was removed under reduced pressure and the compound separated was recrystallised using methanol thrice [11], [36].

Synthesis of 4-bromo-2-chloro-1-(prop-2-ynyloxy)benzene (2a)

Brown solid, M.p. 29°C, 79% Yield, 1H-NMR (400 MHz, CDCl3): δ = 7.50 (d, J = 2.4 Hz, 1H-Ar), 7.33–7.25 (m, 1H-Ar), 6.96 (d, J = 8.8 Hz, 1H-Ar), 4.74 (d, J = 2.4 Hz, 2H-CH2), 2.53 (t, 1H-acetylene). 13C-NMR (100 MHz, CDCl3+ CD3OD): δ = 156.5, 134, 129.6, 122.2, 75.2, 51.2; EIMS (m/z -ion mode): 245 [M-H−]; [M-CH2CCH fragment]− = 206; [M-Br fragment]− = 165.

Synthesis of 2-bromo-4-chloro-1-(prop-2-ynyloxy)benzene (2b)

Brown liquid. 78% Yield, 1H-NMR (400 MHz, CDCl3): δ = 7.54 (d, J = 2.4 Hz, 1H-Ar), 7.23–7.15 (m, 1H-Ar), 6.98 (d, J = 8.8 Hz, 1H-Ar), 4.77 (d, J = 2.0 Hz, 2H-CH2), 2.53 (t, 1H-acetylene). 13C-NMR (100 MHz, CDCl3+ CD3OD): δ = 161, 137.5, 131, 125.2, 115.5, 76.8, 72.1, 51.2; EIMS (m/z -ion mode): 245 [M-H−]; [M-CH2CCH fragment]− = 206; [M-OCH2CCH fragment]− = 191; [M-Br fragment]− = 165.

Synthesis of 2,4-dibromo-1-(prop-2-ynyloxy)benzene (2c)

Brown solid. M.p. 157.95°C, 85% Yield, 1H-NMR (600 MHz, CDCl3): δ = 7.68 (d, J = 2.4 Hz, 1H-Ar), 7.39–7.30 (m, 1H-Ar), 6.95 (d, J = 9.0 Hz, 1H-Ar), 4.76 (d, J = 2.4 Hz, 2H-CH2), 2.55 (t, 1H-acetylene). 13C-NMR (100 MHz, CDCl3+ CD3OD): δ = 167.9, 140.7, 127.8, 116, 76.5, 74.1, 51.2; EIMS (m/z -ion mode): 289 [M-H−]; [M-CH2CCH and CO fragment]− = 221; [M-Br fragment]− = 207; [M-OCH2CCH and Br fragment]− = 149.

Synthesis of 2-bromo-4-methyl-1-(prop-2-ynyloxy)benzene (2d)

Yellow oily liquid. 74% Yield, 1H-NMR (400 MHz, CDCl3): δ = 7.27 (d, J = 2.4 Hz, 1H-Ar), 6.97–6.88 (m, 1H-Ar), 6.67 (d, J = 9 Hz 1H-Ar), 4.69 (d, J = 2.1 Hz, 2H-CH2), 2.99 (t, 1H-acetylene), 1.55 (s, 3H-CH3). 13C-NMR (100 MHz, CDCl3+ CD3OD): δ = 157, 138.9, 129, 79.3, 75.7, 51.2, 19.8; EIMS (m/z -ion mode): 224 [M-H−]; [M-CH2CCH fragment]− = 186; [M-Br fragment]− = 145; [M-CH2CCH and Br fragment]− = 107.

2-bromo-4-fluoro-1-(prop-2-ynyloxy)benzene (2e)

Brown liquid. 79% Yield, 1H-NMR (400 MHz, CDCl3): δ = 7.02–6.97 (m, 3H-Ar), 4.72 (d, J = 2. 4 Hz, 2H-CH2), 2.51 (t, 1H-acetylene). 13C-NMR (100 MHz, CDCl3+ CD3OD): δ = 154.8, 124.3, 120.1, 79.4, 55.6; EIMS (m/z -ion mode): 231 [M-H−]; [M-CH2CCH fragment]− = 193; [M-CO and CH2CCH fragment]− = 165.

Synthesis of 1-nitro-4-(prop-2-ynyloxy)benzene (2f)

Yellow crystals. M.p. 129°C, 76% Yield, ­1H-NMR (400 MHz, CDCl3): δ = 8.216 (d, J = 9 Hz, 1H-Ar), 7.05 (d, J = 9 Hz, 1H-Ar), 4.77 (d, J = 2.4 Hz, 2H-CH2), 2.56 (t, 1H-acetylene). 13C-NMR (100 MHz, CDCl3+ CD3OD): δ = 166.5, 142.2, 129, 77, 57.8; EIMS (m/z -ion mode): 177 (M-H−]; [M-NO2 fragment]− = 131; [M-NO2 and OCH2CCH fragment]− = 77.

Synthesis of 4,4′-(propane-2,2-diyl)bis((prop-2-ynyloxy)benzene) (4a)

Light brown greasy liquid. 73% Yield, 1HNMR (600 MHz, CDCl3): δ = 7.164–7.147 (m, 4H-Ar), 7.103–7.083 (m, 4H-Ar), 4.66 (d, J = 2.4 Hz, 4H-CH2), 2.90 (s, 6H-CH3), 2.52 (t, 2H-acetylene). 13C-NMR (100 MHz, CDCl3+ CD3OD): δ = 156, 151, 130.9, 117, 77.5, 31.8; EIMS (m/z -ion mode): 304 [M-H−]; [M-CH3 fragment]− = 289; [M-CH2CCH fragment]− = 266; [M-benzene, CH3 and OCH2CCH fragment]− = 169.

Synthesis of 4,4′-sulfonylbis((prop-2-ynyloxy)benzene) (4b)

White solid. M.p. 136°C, 69% Yield, 1H-NMR (400 MHz, CDCl3): δ = 7.86–7.83 (m, 4H-Ar), 7.24–7.00 (m, 4H-Ar), 4.71 (d, J = 2. 4 Hz, 4H-CH2), 2.52 (t, 2H-acetylene). 13C-NMR (100 MHz, CDCl3+ CD3OD): δ = 170, 140.7, 128, 119.3, 80.4, 77.5; EIMS (m/z -ion mode): 325 [M-H−]; [M-CH2CCH fragment]− = 288; [M-2CH2CCH fragment]− = 250; [M- CH2CCH and CO fragment]− = 223; [M- CH2CCH and 2CO fragment]− = 195.

Synthesis of 1-(prop-2-ynyloxy)naphthalene (6a)

Light brown liquid. 71% Yield, 1H-NMR (400 MHz, CDCl3): δ = 7.77–7.73 (m, 3H-Ar), 7.45–7.32 (m, 3H-Ar), 7.18–7.09 (m, 1H-Ar), 4.80 (d, J = 2.0 Hz, 2H-CH2), 2.53 (t, 1H-acetylene). 13C-NMR (100 MHz, CDCl3+ CD3OD): δ = 158, 135, 130.6, 126, 77.8, 63; EIMS (m/z -ion mode): 182 [M-H−]; [M-CH2CCH fragment]− = 143; [M-CH2CCH and CO fragment]− = 115; [M-benzene and OCH2CCH fragment]− = 77.

Synthesis of 2-(prop-2-ynyloxy)naphthalene (6b)

Dark brown greasy liquid. 73% yield, 1H-NMR (400 MHz, CDCl3): δ = 7.82–6.75 (m, 7H-Ar), 4.81 (d, J = 2.07 Hz, 2H-CH2), 3.01 (t, 1H-acetylene). 13C-NMR (100 MHz, CDCl3+ CD3OD): δ = 160, 128.3, 126, 122.7, 116.5, 77.5, 58; EIMS (m/z -ion mode): 182 [M-H−]; [M-CH2CCH fragment]− = 143; [M-CH2CCH and CO fragment]− = 115; [M-benzene and OCH2CCH fragment]− = 77.

Synthesis of 4-bromo-2-methyl-N,N-di(prop-2-ynyl)aniline (8a)

Dark brown liquid. 68% Yield, 1H-NMR (400 MHz, CDCl3): δ = 7.20 (d, J = 1.96 Hz, 1H-Ar), 7.14–7.05 (m, 1H-Ar), 6.58 (d, J = 9 Hz, 1H-Ar), 3.94 (d, J = 2.4 Hz, 2H-CH2), 2.71 (t, 1H-acetylene), 2.18 (s, 3H-CH3), 1.18 (s, 1H-NH). 13C-NMR (100 MHz, CDCl3+ CD3OD): δ = 154.2, 140, 138.9, 120.4, 79, 75.3, 45, 18.5; EIMS (m/z -ion mode): 224 [M-H−]; [M-CH2CCH fragment]− = 184; [M-Br fragment]− = 144; [M-CH2CCH and Br fragment]− = 106.

Synthesis of 2-bromo-4-methyl-N-(prop-2-ynyl)aniline (8b)

Dark brown liquid. 71% Yield, 1H-NMR (400 MHz, CDCl3): δ = 7.26 (s, 1H-Ar), 6.98–6.91 (m, 1H-Ar), 6.64 (d, J = 8 Hz, 1H-Ar), 3.96–3.90 (m, 4H-CH2), 2.22 (t, 2H-acetylene), 1.55 (s, 3H-CH3). 13C-NMR (100 MHz, CDCl3+ CD3OD): δ = 140.5, 137.8, 129.9, 117, 80, 76.5, 46, 20.9; EIMS (m/z -ion mode): 224 [M-H−]; [M-CH2CCH fragment]− = 184; [M-Br fragment]− = 144; [M-CH2CCH and Br fragment]− = 106.

Synthesis of 4-bromo-3-methyl-N-(prop-2-ynyl)aniline (8c)

Dark brown solid. M.p. 40.85°C, 70% Yield, 1H-NMR (400 MHz, CDCl3): δ = 7.17 (d, J = 6 Hz, 1H-Ar), 6.63–6.55 (m, 1H-Ar), 6.36 (d, J = 7 Hz, 1H-Ar), 4.06 (d, J = 2.4 Hz, 4H-CH2), 2.86 (t, 2H-acetylene), 2.18 (s, 3H-CH3). 13C-NMR (100 MHz, CDCl3+ CD3OD): δ = 150.6, 135.9, 130, 117.2, 80, 75, 45, 23.8; EIMS (m/z -ion mode): 224 [M-H−]; [M-CH2CCH fragment]− = 184; [M-Br fragment]− = 144; [M-CH2CCH and Br fragment]− = 106.

Synthesis of N-(prop-2-ynyl)naphthalen-1-amine (8d)

Brown greasy liquid. 69% Yield, 1H-NMR (400 MHz, CDCl3): δ = 7.78–6.7 (m, 7H-Ar), 4.11 (d, J = 2.40 Hz, 2H-CH2), 2.88 (t, 1H-acetylene), 2.26 (s, 1H-NH). 13C-NMR (100 MHz, CDCl3+ CD3OD): δ = 149, 135, 126, 107.6, 80.8, 75.5, 31; EIMS (m/z -ion mode): 180 [M-H−]; M-CH2CCH fragment]− = 143; [M-HCN fragment]− = 115; [M-benzene and HNCH2CCH]− = 77.

Synthesis of N-(prop-2-ynyl)-4-(prop-2-ynyloxy)aniline (10)

Dark brown greasy liquid. 53% Yield, 1H-NMR (400 MHz, CDCl3): δ = ): δ = 7.24–7.03 (m, 4H-Ar), 3.98 (d, J = 2.40 Hz, 6H-CH2), 2.88 (t, 3H-acetylene). 13C-NMR (100 MHz, CDCl3+ CD3OD): δ = 149, 145.5, 118.7, 118.6, 76, 71, 61, 45; EIMS (m/z -ion mode): 185 = [M-H−]; [M-CH2CCH fragment]− = 146; [M-2CH2CCH fragment]− = 108; [M-2CH2CCH and CO fragment]− = 80.

Antiurease Activity

Antiurease activity of the synthesized compounds was determined by using the modified phenol-hypochlorite method [37]. Varying concentrations were used to prepare the urease inhibition curve of Thiourea (a known inhibitor of Urease) in the reaction mixture. Phosphate buffer solution of pH 7 containing 1 unit of enzyme was added about 200 µl in the test tube which was followed by the addition of 230 µl of phosphate buffer and 20 µl of thiourea from a scrupulous stock solution for the particular concentration of thiourea in the reaction mixture respectively. Test sample solutions were added instead of thiourea solution in case of test samples. The reaction mixture were mixed and incubated at 25°C for 5 min. 400 µl of urea stock (20 mM) was added in each test tube. In order to allow the action of urease on urea, all the test tubes were incubated at 40°C. Phenol hypochlorite reagent (1150 µl) was added after 10 min incubation at 40°C. Test tubes were again incubated at 56°C for 25 min. A blue coloured complex was formed in the reaction mixture. The samples were allowed to cool for 5 min and then their absorbance values were measured at 625 nm and the %age inhibition was calculated. Experiment was repeated three times to get the SD values.

NO Scavenging Activity

Solutions of known concentration were prepared by dissolving the synthesized compounds in appropriate solvents. [38] A mixture of sample solution (20 µl), 10 mM sodium nitropruside solution (200 µl) and phosphate buffer of 7.4 pH (1780 µl) was taken in a dry test tube and the mixture was incubated at 37°C for 2 hours. 200 µl Griess reagent (0.3% Sulphanilic acid in glacial acetic acid, 0.1% Naphthyl ethylene diamine HCL (NED): Mixed equal volume of both solutions just before use) was added after the incubation period is over. After 20 min keeping the solution at room temperature, its absorbance at 528 nm was measured. Each sample was analyzed in triplicate. Positive control of any known antioxidant and control of all samples were run in parallel. Use of negative control was to calibrate the instrument. Sample blanks were also prepared in case if the samples were coloured. Correction in the absorbance values was made by subtracting the sample blank reading from the sample reading.

Antibacterial Activity

Disc diffusion method was used for the determination of antibacterial activity. [39] synthetic organic compounds were examined to evaluate their antibacterial potential against four different strains of bacteria i.e. Staphlococcus aureus (Gram + ive), Pseudomonas- aeroginosa (Gram−ive) and Escherichia coli (Gram−ive), Bacillus subtilis (Gram + ive), Salmonella typhi (Gram−ive) and Shigella flexneri (−ive). The synthetic organic compounds were dissolved in an appropriate solvent to get the solution of known concentration (5 µg/µl or 10 µg/µl). In order to prepare discs of different potencies known volume of extract/synthetic organic compound solution was applied on the discs, air dried and used. After preparation of the sterilized nutrient agar and nutrient broth medium, the sterilized nutrient agar medium was poured under aseptic conditions into sterile glass petri dishes/plates. A known volume of bacterial growth culture can also be poured on the surface of agar medium solidified in petri dishes. After inoculation petri plates were kept at room temperature for 15–30 minutes so that the poured medium is adsorbed. All the discs, including test sample, +ive and –ve controls were placed onto the inoculated nutrient agar medium solidified in petri dishes with the help of sterile forceps and incubated the petri plates at 37°C±2°C for 16–24 hours. Zone of inhibition was measured in mm using ordinary scale. Experiment was repeated three times to get the SD values.

Conclusions

We have reported the synthesis of (prop-2-ynyloxy)benzene derivatives with efficient yields under mild conditions. Some of the reactions were proceeded using comparatively harsh conditions. Using more than one method helped in comparison of reaction conditions and finding out the best one. Potassium carbonate is a mild base, which provides best reaction conditions. Other bases used were comparatively harsh which may also affect the aromatic ring rendring it unfavorable for reaction products. Harsh bases like LiH, NaOH deactivate the aromatic ring. Acetone favours SN2 type reaction providing aprotic polar conditions so acetone and potassium carbonate were proven to be best for the synthesis of desired products. The synthesized compounds were proved to be good antiurease, antioxidant and antibacterial substances. Phenolic Compounds containing electron donating groups were proved to be better urease inhibitors and good NO scavenging activity than those compounds containing electron withdrawing groups. In contrast synthesized phenolic compounds containing both electron donating and electron withdrawing functionality gave better results against bacterial strains. It also noted Aniline derivatives showed lesser activity than phenolic compounds. The results of this study revealed that these compounds may have potential inhibitory activity and can be used as antibacterial, antiurease and antioxidant molecules.
  17 in total

1.  A potent and highly selective inhibitor of human alpha-1,3-fucosyltransferase via click chemistry.

Authors:  Lac V Lee; Michael L Mitchell; Shih-Jung Huang; Valery V Fokin; K Barry Sharpless; Chi-Huey Wong
Journal:  J Am Chem Soc       Date:  2003-08-13       Impact factor: 15.419

Review 2.  Click chemistry: 1,2,3-triazoles as pharmacophores.

Authors:  Sandip G Agalave; Suleman R Maujan; Vandana S Pore
Journal:  Chem Asian J       Date:  2011-08-29

3.  A chemoselective approach for the accelerated synthesis of well-defined dendritic architectures.

Authors:  Per Antoni; Daniel Nyström; Craig J Hawker; Anders Hult; Michael Malkoch
Journal:  Chem Commun (Camb)       Date:  2007-05-14       Impact factor: 6.222

Review 4.  Cu-catalyzed azide-alkyne cycloaddition.

Authors:  Morten Meldal; Christian Wenzel Tornøe
Journal:  Chem Rev       Date:  2008-08       Impact factor: 60.622

5.  Syntheses and antibacterial activity of phendioxy substituted cyclic enediynes.

Authors:  Mukesh Chandra Joshi; Gopal Singh Bisht; Diwan S Rawat
Journal:  Bioorg Med Chem Lett       Date:  2007-03-12       Impact factor: 2.823

6.  Palladium-catalyzed heteroannulation leading to heterocyclic structures with two heteroatoms: a highly regio- and stereoselective synthesis of (Z)-4-alkyl-2-alkyl(aryl)idene-3,4-dihydro-2H-1,4-benzoxazines and (Z)-3-alkyl(aryl)idene-4-tosyl-3,4-dihydro-2H-1,4-benzoxazines.

Authors:  N G Kundu; G Chaudhuri; A Upadhyay
Journal:  J Org Chem       Date:  2001-01-12       Impact factor: 4.354

7.  Peptidotriazoles on solid phase: [1,2,3]-triazoles by regiospecific copper(i)-catalyzed 1,3-dipolar cycloadditions of terminal alkynes to azides.

Authors:  Christian W Tornøe; Caspar Christensen; Morten Meldal
Journal:  J Org Chem       Date:  2002-05-03       Impact factor: 4.354

8.  Bioconjugation by copper(I)-catalyzed azide-alkyne [3 + 2] cycloaddition.

Authors:  Qian Wang; Timothy R Chan; Robert Hilgraf; Valery V Fokin; K Barry Sharpless; M G Finn
Journal:  J Am Chem Soc       Date:  2003-03-19       Impact factor: 15.419

9.  Efficient synthesis of 2-amino-6-arylbenzothiazoles via Pd(0) Suzuki cross coupling reactions: potent urease enzyme inhibition and nitric oxide scavenging activities of the products.

Authors:  Yasmeen Gull; Nasir Rasool; Mnaza Noreen; Faiz-Ul-Hassan Nasim; Asma Yaqoob; Shazia Kousar; Umer Rasheed; Iftikhar Hussain Bukhari; Muhammad Zubair; Md Saiful Islam
Journal:  Molecules       Date:  2013-07-25       Impact factor: 4.411

10.  Pseudo-four component synthesis of mono- and di-benzylated-1,2,3-triazoles derived from aniline.

Authors:  Daniel Mendoza-Espinosa; Guillermo E Negron-Silva; Leticia Lomas-Romero; Atilano Gutierrez-Carrillo; Rosa Santillán
Journal:  Molecules       Date:  2013-12-20       Impact factor: 4.411

View more
  4 in total

1.  Synthesis and biological evaluation of lipophilic teicoplanin pseudoaglycon derivatives containing a substituted triazole function.

Authors:  Zsolt Szűcs; Magdolna Csávás; Erzsébet Rőth; Anikó Borbás; Gyula Batta; Florent Perret; Eszter Ostorházi; Réka Szatmári; Evelien Vanderlinden; Lieve Naesens; Pál Herczegh
Journal:  J Antibiot (Tokyo)       Date:  2016-06-29       Impact factor: 2.649

Review 2.  A review on the development of urease inhibitors as antimicrobial agents against pathogenic bacteria.

Authors:  Yuri F Rego; Marcelo P Queiroz; Tiago O Brito; Priscila G Carvalho; Vagner T de Queiroz; Ângelo de Fátima; Fernando Macedo
Journal:  J Adv Res       Date:  2018-05-04       Impact factor: 10.479

3.  In silico DFT study, molecular docking, and ADMET predictions of cytidine analogs with antimicrobial and anticancer properties.

Authors:  Kazi M Rana; Jannatul Maowa; Asraful Alam; Sujan Dey; Anowar Hosen; Imtiaj Hasan; Yuki Fujii; Yasuhiro Ozeki; Sarkar M A Kawsar
Journal:  In Silico Pharmacol       Date:  2021-07-06

4.  Innovative Three-Step Microwave-Promoted Synthesis of N-Propargyltetrahydroquinoline and 1,2,3-Triazole Derivatives as a Potential Factor Xa (FXa) Inhibitors: Drug Design, Synthesis, and Biological Evaluation.

Authors:  Fabián Santana-Romo; Carlos F Lagos; Yorley Duarte; Francisco Castillo; Yanina Moglie; Miguel A Maestro; Nitin Charbe; Flavia C Zacconi
Journal:  Molecules       Date:  2020-01-23       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.